Application
Mupirocin has been used:for kinetic assayto assess its resistance by performing turbidity assayto determine its antimicrobial susceptibility
Biochem/physiol Actions
Antibiotic; inhibits isoleucyl-tRNA synthetase (IRS).
Features and Benefits
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
General description
Mupirocin is produced by Pseudomonas fluorescens. It exhibits bacteriostatic action. Mupirocin is used to treat impetigo and skin infections.
Packaging
50, 100 mg in glass bottle
This product has met the following criteria: